We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ranbaxy Bids For Second Look In Lipitor Feud

Law360 (August 17, 2006, 12:00 AM EDT) -- Swiping back in the battle over Pfizer Inc.’s Lipitor, Indian drug maker Ranbaxy Laboratories Ltd. on Wednesday asked a U.S. appeals court to reconsider part of a ruling that would block a generic version of the cholesterol medicine from hitting the market until 2010.

On August 2, the U.S. Court of Appeals for the Federal Circuit issued a mixed ruling in the long-running battle over Lipitor, the world’s best-selling drug.

The Federal Circuit’s ruling affirmed a lower court’s decision that a patent covering the drug that...
To view the full article, register now.